Duke Health News company blog
A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans
DURHAM, N.C. – An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.The finding, reported May 17 in the journal Cell, not only provides proof that a vaccine…
- Points
- 282
- HN comments
- 68
- Submissions
- 1
- Cited by
- 0 commenters
On Hacker News
| Submitted | Title on HN | Points | Comments |
|---|---|---|---|
| May 17, 2024 | A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans by geox | 282 | 68 |
